These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Covered metallic stents with an anti-migration design vs. uncovered stents for the palliation of malignant gastric outlet obstruction: a multicenter, randomized trial. Lee H, Min BH, Lee JH, Shin CM, Kim Y, Chung H, Lee SH. Am J Gastroenterol; 2015 Oct; 110(10):1440-9. PubMed ID: 26372507 [Abstract] [Full Text] [Related]
3. Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study. Kim CG, Choi IJ, Lee JY, Cho SJ, Park SR, Lee JH, Ryu KW, Kim YW, Park YI. Gastrointest Endosc; 2010 Jul; 72(1):25-32. PubMed ID: 20381802 [Abstract] [Full Text] [Related]
8. Predictors of stent dysfunction after self-expandable metal stent placement for malignant gastric outlet obstruction: tumor ingrowth in uncovered stents and migration of covered stents. Hori Y, Naitoh I, Hayashi K, Ban T, Natsume M, Okumura F, Nakazawa T, Takada H, Hirano A, Jinno N, Togawa S, Ando T, Kataoka H, Joh T. Surg Endosc; 2017 Oct; 31(10):4165-4173. PubMed ID: 28281116 [Abstract] [Full Text] [Related]
9. Metallic stents for gastric outlet obstruction: reintervention rate is lower with uncovered versus covered stents, despite similar outcomes. Maetani I, Ukita T, Tada T, Shigoka H, Omuta S, Endo T. Gastrointest Endosc; 2009 Apr; 69(4):806-12. PubMed ID: 19136108 [Abstract] [Full Text] [Related]
10. Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial. Kitano M, Yamashita Y, Tanaka K, Konishi H, Yazumi S, Nakai Y, Nishiyama O, Uehara H, Mitoro A, Sanuki T, Takaoka M, Koshitani T, Arisaka Y, Shiba M, Hoki N, Sato H, Sasaki Y, Sato M, Hasegawa K, Kawabata H, Okabe Y, Mukai H. Am J Gastroenterol; 2013 Nov; 108(11):1713-22. PubMed ID: 24042190 [Abstract] [Full Text] [Related]
11. Which types of stent, uncovered or covered, should be used in gastric outlet obstructions? Kim GH, Kang DH, Lee DH, Heo J, Song GA, Cho M, Yang US. Scand J Gastroenterol; 2004 Oct; 39(10):1010-4. PubMed ID: 15513343 [Abstract] [Full Text] [Related]
12. Endoscopic self-expandable metallic stenting for palliation of malignant gastric outlet obstruction in Southeast Asia. Lye TJ, Goh YC, Eng AK, Ong HS, Wong WK, Chan WH. ANZ J Surg; 2016 Jun; 86(6):464-8. PubMed ID: 25288128 [Abstract] [Full Text] [Related]
14. Safety and benefits of self-expandable metallic stents with chemotherapy for malignant gastric outlet obstruction. Miyabe K, Hayashi K, Nakazawa T, Sano H, Yamada T, Takada H, Naitoh I, Shimizu S, Kondo H, Nishi Y, Yoshida M, Umemura S, Hori Y, Kato A, Ohara H, Joh T. Dig Endosc; 2015 Jul; 27(5):572-81. PubMed ID: 25559626 [Abstract] [Full Text] [Related]
15. Efficacy and safety of the new WallFlex enteral stent in palliative treatment of malignant gastric outlet obstruction (DUOFLEX study): a prospective multicenter study. van Hooft JE, Uitdehaag MJ, Bruno MJ, Timmer R, Siersema PD, Dijkgraaf MG, Fockens P. Gastrointest Endosc; 2009 May; 69(6):1059-66. PubMed ID: 19152912 [Abstract] [Full Text] [Related]
16. Covered versus uncovered metal stents for malignant gastric outlet obstruction: a systematic review and meta-analysis. Tringali A, Costa D, Anderloni A, Carrara S, Repici A, Adler DG. Gastrointest Endosc; 2020 Dec; 92(6):1153-1163.e9. PubMed ID: 32565187 [Abstract] [Full Text] [Related]
17. Individualization of metal stents for management of gastric outlet obstruction caused by distal stomach cancer: a prospective study. Shi D, Bao YS, Liu YP. Gastrointest Endosc; 2013 Aug; 78(2):277-84. PubMed ID: 23528652 [Abstract] [Full Text] [Related]